Publicado 4 números por año
ISSN Imprimir: 0731-8898
ISSN En Línea: 2162-6537
IF:
2.4
5-Year IF:
2.8
Immediacy Index:
0.5
Eigenfactor:
0.00049
JCI:
0.59
SJR:
0.429
SNIP:
0.507
CiteScore™::
3.9
H-Index:
49
Indexed in
Insulin Protects against Brain Oxidative Stress with an Apparent Effect on Episodic Memory in Doxorubicin-Induced Cognitive Dysfunction in Wistar Rats
Get access
SINOPSIS
The present study was aimed at assessing the protective effect of insulin against doxorubicin (DOX)-induced cognitive dysfunction in Wistar rats. Cognitive function for episodic memory was assessed by a novel object recognition task (NORT) in male Wistar rats. Oxidative stress markers−SOD, catalase, glutathione, and lipid peroxidation−in the hippocampus and frontal cortex were assessed using colorimetric methods. Doxorubicin treatment (2.5 mg/kg, i.p., every 5 days for 50 days) reduced recognition and discriminative indices in NORT with increased oxidative stress in the brain. A nonhypoglycemic dose of insulin (0.5 IU/kg, i.p.) significantly reduced brain oxidative stress (MDA) induced by doxorubicin with an increase in the antioxidant defense systems (SOD, catalase, and GSH). Rats treated with combined insulin and DOX spent comparatively more time with the novel object when compared to the non-novel objects; however, the observed difference was not statistically significant. An apparent improvement (p < 0.26) in recognition of the novel object was observed against the damage induced by doxorubicin. These results suggest that insulin reduces brain oxidative stress and apparently improves doxorubicin-induced cognitive dysfunction in Wistar rats.
-
Kim Yu, Jeong Soo-Jin, Seo Chang-Seob, Lim Hye-Sun, Sohn Eunjin, Yun Jiyeon, Kim Bu-Yeo, Simultaneous Determination of the Traditional Herbal Formula Ukgansan and the In Vitro Antioxidant Activity of Ferulic Acid as an Active Compound, Molecules, 23, 7, 2018. Crossref
-
El-Agamy Sara Emad, Abdel-Aziz Amal Kamal, Esmat Ahmed, Azab Samar S., Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain, Cancer Chemotherapy and Pharmacology, 84, 1, 2019. Crossref
-
Farruggia Michael C., Small Dana M., Effects of adiposity and metabolic dysfunction on cognition: A review, Physiology & Behavior, 208, 2019. Crossref
-
Fernandez Harvey R., Varma Ashima, Flowers Sarah A., Rebeck George William, Cancer Chemotherapy Related Cognitive Impairment and the Impact of the Alzheimer’s Disease Risk Factor APOE, Cancers, 12, 12, 2020. Crossref
-
Huang Qian , Liu Chan , Li Jia‑Rui , Zhang Ling , Huang Fu‑Chang , Wang Dan , Luo Ya‑Jing , Incremental effect of liraglutide on traditional insulin injections in rats with type 2 diabetes mellitus by maintaining glycolipid metabolism and cardiovascular function, Experimental and Therapeutic Medicine, 2019. Crossref
-
Onzi Giovana R., D’Agustini Nathalia, Garcia Solange C., Guterres Silvia S., Pohlmann Paula R., Rosa Daniela D., Pohlmann Adriana R., Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions, Drug Safety, 45, 6, 2022. Crossref
-
Jordá Adrián, Aldasoro Martin, Campo-Palacio Ignacio, Vila Jose, Aldasoro Constanza, Campos-Campos Juan, Colmena Carlos, Singh Sandeep, Obrador Elena, Valles Soraya, Facilitation of Insulin Effects by Ranolazine in Astrocytes in Primary Culture, International Journal of Molecular Sciences, 23, 19, 2022. Crossref